Evidence map›Paper›PMID 38648495›Full record

ArticleAnnals of medicine2024

Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.

Sandra Hertz, Jacqueline Moltzau Anderson, Hans Linde Nielsen, Claire Schachtschneider, Kathryn E McCauley, Mustafa Özçam, Lone Larsen, Susan V Lynch, Henrik Nielsen

Open access · goldAbstract read
In one paragraph

Article in Annals of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. 3'-Sialyllactose andGut microbes · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Sandra HertzDepartment of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0002-7202-7232
Jacqueline Moltzau AndersonDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-1398-5980
Hans Linde NielsenDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.ORCID 0000-0002-2370-417X
Claire SchachtschneiderDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, USA.
Kathryn E McCauleyDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, USA.
Mustafa ÖzçamDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-1834-6942
Lone LarsenDepartment of Gastroenterology, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0003-4067-2381
Susan V LynchDepartment of Medicine, Division of Gastroenterology, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0001-5695-7336
Henrik NielsenDepartment of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0002-0841-8255
University of California, San Francisco · USAalborg University Hospital · DK

Funding

TRAINING PROGRAM IN PEDIATRIC GASTROENTEROLOGY/NUTRITIONT32DK007762 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI James Bayrer · 1998 to 2026
$7.3M
NIDDK NIH HHS T32 DK007762
6 · The paper itself

Abstract

introductionA large proportion of patients with inflammatory bowel disease (IBD) experience IBD-related inflammatory conditions outside of the gastrointestinal tract, termed extraintestinal manifestations (EIMs) which further decreases quality of life and, in extreme cases, can be life threatening. The pathogenesis of EIMs remains unknown, and although gut microbiota alterations are a well-known characteristic of patients with IBD, its relationship with EIMs remains sparsely investigated. This study aimed to compare the gut microbiota of patients with IBD with and without EIMs.

methodsA total of 131 Danish patients with IBD were included in the study, of whom 86 had a history of EIMs (IBD-EIM) and 45 did not (IBD-C). Stool samples underwent 16S rRNA sequencing. Amplicon sequence variants (ASVs) were mapped to the Silva database. Diversity indices and distance matrices were compared between IBD-EIM and IBD-C. Differentially abundant ASVs were identified using a custom multiple model statistical analysis approach, and modules of co-associated bacteria were identified using sparse correlations for compositional data (SparCC) and related to patient EIM status.

resultsPatients with IBD and EIMs exhibited increased disease activity, body mass index, increased fecal calprotectin levels and circulating monocytes and neutrophils. Microbiologically, IBD-EIM exhibited lower fecal microbial diversity than IBD-C (Mann-Whitney's test,

conclusionsThe fecal microbiota in IBD patients with EIMs is distinct from that in IBD patients without EIM and could be important for EIM pathogenesis.

Indexed as

FecesGastrointestinal MicrobiomeInflammatory Bowel DiseasesRNA, Ribosomal, 16SAdultAgedDenmarkFemaleHumansLeukocyte L1 Antigen ComplexMaleMiddle AgedLeukocyte L1 Antigen ComplexRNA, Ribosomal, 16S16S rRNA sequencingCrohn’s diseaseextraintestinal manifestationsGut microbiotainflammatory bowel diseaseulcerative colitis

Identifiers

PMID38648495
PMCPMC11036898
OpenAlexW4394993677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.